nach oben

Erschienen in:

2020 | Natürliche Kontrazeption | OriginalPaper | Buchkapitel

14. Zyklus-Apps und Mess-Systeme

verfasst von : Elisabeth Raith-Paula, Petra Frank-Herrmann

Erschienen in: Natürliche Familienplanung heute

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Es werden laufend Zyklus-Apps und technische Mess-Systeme entwickelt, die das fruchtbare Fenster im Zyklus anzeigen. Dabei gibt es Produkte, die für diese Zielsetzung von vornherein unbrauchbar sind, andere beruhen auf bekannten, sicheren NFP-Methoden und wieder andere befinden sich noch gänzlich im Experimentierstadium. Dieses Kapitel setzt sich detailliert mit den Grundlagen und der Sinnhaftigkeit der einzelnen Produkte auseinander, inklusive deren Eignung für Kinderwunsch und Verhütung. Es beleuchtet ihre Sicherheit und Praktikabilität und informiert über neue, spannende Entwicklungen. Enttäuschend sind häufig die von den Herstellern selbst gelieferten Daten. CE-Kennzeichnung, TÜV-Siegel und FDA-Zulassungen sind bezüglich der Zuverlässigkeit der Produkte nicht aussagekräftig. Dieses Kapitel enthält sehr viele Details und ist in erster Linie für Experten und speziell Interessierte gedacht. Zur allgemeinen Orientierung findet sich am Ende eine ausführliche Zusammenfassung.

Albrecht BH, Fernando RS, Regas J, Betz G (1985) A new method for predicting and confirming ovulation. Fertil Steril 44:200–205 PubMedCrossRef

Alliende ME (2002) Mean versus individual hormonal profiles in the menstrual cycle. Fertil Steril 78:90–95 PubMedCrossRef

Arbeitsgruppe NFP (2018) Natürlich und sicher. TRIAS-Verlag, Das Praxisbuch

Bachhofer D (1997) Der Miniaturcomputer „Babycomp/Ladycomp“ in der Natürlichen Familienplanung. Med Dissertation, Universität Düsseldorf

Baird DD, McConnaughey DR, Weinberg CR, Musey PI, Collins DC, Kesner JS, Knecht EA, Wilcox AJ (1995) Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. Epidemiology 6:547–550 PubMedCrossRef

Barbato M (1992) The salivary ferning by the use of PG/53 as diagnostic test to control fertile and infertile days of menstrual cycle. Gynecol Endocrinol (Suppl 1)

Barbato M, Pandolfi A, Guida M (1993) A new diagnostic aid for natural family planning. Adv Contracept 9:335–340 PubMedCrossRef

Bedford JL, Prior JC, Hitchcock CL, Barr SI (2009) Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of waketime variability. Eur J Obstet Gynecol Reprod Biol 146:76–80. https://doi.org/10.1016/j.ejogrb

Behre H (2001) Trial protocol and sample result of a study comparing the clearplan easy fertility monitor with serum hormone and vaginal ultrasound measurements in the determination of ovulation. J Int Med Res 29(Suppl 1):21A–27A PubMedCrossRef

Behre H, Kuhlage J, Gassner C, Sonntag B, Schem C, Schneider HP et al (2000) Prediction of ovulation by urinary hormone measurements with the home use clearplan fertility monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 15:2478–2482 PubMedCrossRef

Berensmann M, Gratzfeld M (2018) Anforderungen für die CE-Kennzeichnung von Apps und Wearables [Requirements for CE-marking of apps and wearables] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61(3):314–320. https://doi.org/10.1007/s00103-018-2694-2.

Berglund Scherwitzl E, Gemzell Danielsson K, Sellberg JA, Scherwitzl R (2016) Fertility awareness-based mobile application for contraception. Eur J Contracept Reprod Health Care 21:234–241. https://doi.org/10.3109/13625187.2016.1154143 CrossRefPubMedPubMedCentral

Berglund Scherwitzl E, Hirschberg AL, Scherwitzl R (2015) Identification and prediction of the fertile window using naturalcycles. Eur J Contracept Reprod Health Care 20:403–408. https://doi.org/10.3109/13625187.2014.988210 CrossRefPubMed

Berglund Scherwitzl E, Lundberg O, Gemzell Danielsson K, Trussell J, Scherwitzl R (2019) Response to “study of contraceptive mobile app fails to provide convincing findings”. Contraception 99:195–196. https://doi.org/10.1016/j.contraception.2018.10.001 CrossRefPubMed

Berglund Scherwitzl E, Lundberg O, Kopp Kallner H, Gemzell Danielssonc K, Trussell J, Scherwitzl R (2017) Perfect-use and typical-use Pearl Index of a contraceptive mobile app. Contraception 96:420–425. https://doi.org/10.1016/j.contraception.2017.08.014

Blackwell LF, Brown JB (1992) Application of time-series analysis for the recognition of increases in urinary estrogens as markers for the beginning of the potentially fertile period. Steroids 57:554–562 PubMedCrossRef

Blackwell LF, Brown JB, Cooke D (1998) Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediolglucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle. Steroids 63:5–13 PubMedCrossRef

Blackwell LF, Brown JB, Vigil P, Gross B, Sufi S, d’Arcangues C (2003) Hormonal monitoring of ovarian activity using the ovarian monitor: part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay. Steroids 68:465–476 PubMedCrossRef

Blackwell LF, Vigil P, Gross B, D’Arcangues C, Cooke DG, Brown JB (2012) Monitoring of ovarian activity by measurement of urinary excretion rates of estroneglucuronide and pregnanediolglucuronide using the ovarian monitor, part II: reliability of home testing. Hum Reprod 27(2):550–557 PubMedCrossRef

Blackwell LF, Vigil P, Alliende ME, Brown S, Festin M, Cooke DG (2016) Monitoring of ovarian activity by measurement of urinary excretion rates using the ovarian monitor, part IV: The relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the postovulatory infertile period. Hum Reprod 31:445–453 PubMed

Bouchard TP, Genuis SJ (2011) Personal fertility monitors for contraception. CMAJ 183:73–76. https://doi.org/10.1503/cmaj.090195 CrossRefPubMedPubMedCentral

Bouchard TP, Fehring RJ, Schneider MM (2018) Achieving pregnancy using primary care interventions to identify the fertile window. Frontiers in Medicine 4:250. https://doi.org/10.3389/fmed.2017.00250 CrossRefPubMedPubMedCentral

Bonnar J, Flynn A, Freundl G, Kirkman R, Royston R, Snowden R (1999) Personal hormone monitoring for contraception. Br J FamPlann 24:128–134

Bremme M, Freundl G, Frank-Herrmann P (1992) Analysis of the computerthermometer „Cyclotest D“ to be used for natural family planning. Adv Contracept 8:221 CrossRef

Brown JB, Blackwell LF, Holmes J, Smyth K (1989) New assays for identifying the fertile period. Suppl Int J Gynecol Obstet 1:111–122 PubMed

Brown JB, Holmes J, Barker G (1991) Use of the home ovarian monitor in pregnancy avoidance. Am J Obstet Gynecol 165:2008–2011 PubMedCrossRef

Calamera JC, Vilar O, Nicholson R (1986) Changes in sialic acid concentration in human saliva during the menstrual cycle. Int J Fertil 31:43–45 PubMed

Cooke DG, Binnie JE, Blackwell LF (2007) Validation of a reference ELISA for estroneglucuronide using urine samples normalized by dilution to a constant rate of urine production. Steroids 72:580–591 PubMedCrossRef

Direito A, Bailly S, Mariane A, Ecochard R (2013) Relationship between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Fertil Steril 99:279–285 PubMedCrossRef

Döring G (1953) Über Veränderungen der Atmung während des Zyklus. Arch Gynecol 182:746–758

Duane M, Contreras A, Jensen ET, White A (2016) The performance of fertility awareness-based method apps marketed to avoid pregnancy. J Am Board Fam Med 29:508–511. https://doi.org/10.3122/jabfm.2016.04.160022 CrossRefPubMed

Durna E (1987) Prediction of ovulation using the „Cue“ vaginal monitor. Clin Reprod Fertil 5:313

Ecochard R, Boehringer H, Rabilloud M, Marret H (2001) Chronological aspects of ultrasonic, hormonal, and other indirect indices of ovulation. BJOG 108:822–829 PubMed

Ecochard R, Leiva R, Bouchard T, Boehringer H, Direito A, Mariani A, Fehring R (2013) Use of urinary pregnanediol 3-glucuronide to confirm ovulation. Steroids 78:1035–1040. https://doi.org/10.1016/j.steroids.2013.06.006 CrossRefPubMed

Ecochard R, Duterque O, Leiva R, Bouchard T, Vigil P (2015) Self-identification of the clinical fertile window and the ovulation period. Fertil Steril 103:1319–1325 PubMedCrossRef

Fatthagian K (1997) Gebrauchssicherheit des Cyclotest 2 plus. Med Dissertation, Universität Düsseldorf

Fazleabas AT, Segraves MM, Khan-Dawood FS (1990) Evaluation of salivary and vaginal electrical resistance for determination of the time of ovulation. Int J Fertil 35:106–111 PubMed

Fehring RJ (1996) A comparison of the ovulation method with the CUE ovulation predictor in determining the fertile period. J Am Acad Nurse Pract 8:461–466 PubMedCrossRef

Fehring RJ, Gaska N (1998) Evaluation of the lady free biotester in determining the fertile period. Contraception 57(5):325–328 PubMedCrossRef

Fehring RJ, Schneider M (2008) Variability in the hormonally estimated fertile phase of the menstrual cycle. Fertil Steril 90:1232–1235 PubMedCrossRef

Fehring RJ, Schneider M (2017) Effectiveness of a natural familiy planning service program. MCN Am J Matern Child Nurs 42:43–49 PubMedCrossRef

Fehring RJ, Raviele K, Schneider M (2004) A comparison of the fertile phase as determined by the clearplan easy fertility monitor and self-assessment of cervical mucus. Contraception 69:9–14 PubMedCrossRef

Fehring RJ, Schneider M, Raviele K, Barron ML (2007) Efficacy of cervical mucus observations plus electronic hormonal fertility monitoring as a method of natural family planning. J Obstet Gynecol Neonatal Nurs 36:152–160 PubMedCrossRef

Fehring RJ, Schneider M, Barron ML (2008) Efficacy of the marquette method of natural family planning. ACN Am J Matern Child Nurs 33(6):348–354 CrossRef

Fehring RJ, Schneider M, Raviele K, Rodrigueza D, Pruszynskic J (2013) Randomized comparison of two Internet-supported fertility-awareness-based methods of family planning. Contraception 88:24–30. https://doi.org/10.1016/j.contraception.2012

Fernando RS, Regas J, Betz G (1987) Prediction of ovulation with the use of oral and vaginal electrical measurements during treatment with clomiphene citrate. Fertil Steril 47:409–415 PubMedCrossRef

Fernando RS, Regas J, Betz G (1988) Ovulation prediction and detection with the cue ovulation predictor. Hum Reprod 3:419–424 PubMedCrossRef

Flynn AM, Collins WP, Royston P, Barbato M, Mena GP, Alliende ME (1997) Volumetric self-sampling of cervicovaginal fluid to determine potential fertility: a multicentre pre-effectiveness study of the Rovumeter. Hum Reprod 12:1826–1831 PubMedCrossRef

Flynn AM, McCarthy AM, Docker M, Royston JP (1988) The temporal relationship between vaginal fluid volumes obtained with the Rovumeter vaginal aspirator and the fertile phase of the cycle. Hum Reprod 3:201–205 PubMedCrossRef

Frank-Herrmann P, Heil J, Gnoth C, Toledo E, Baur S, Pyper C et al (2007) The effectiveness of a fertility awareness based method to avoid pregnancy in relation to a couple’s sexual behaviour during the fertile time: a prospective longitudinal study. Hum Reprod 22:1310–1319

Frank-Herrmann P, Stanford JB, Freundl G (2017) Fertility awareness-based mobile application. Eur J Contracept Reprod Health Care 22:396–397. https://doi.org/10.1080/13625187.2017.1362691 CrossRefPubMed

Frank-Herrmann P, Freis A, Freundl-Schütt T, Wallwiener L-M, Baur S, Freundl G, Raith-Paula E, Strowitzki T (2019a) Zyklus-Apps zur Verhütung – sicher oder Gesellschaftsspiel? Gynäkologe 52:90. https://doi.org/10.1007/s00129-018-4358-6 CrossRef

Frank-Herrmann P, Freis A, Freundl-Schütt T, Wallwiener L-M, Baur S, Freundl G, Strowitzki T (2019b) Zyklus-Apps, smarte Armbänder und Co: Ist das die Verhütung der Zukunft? Frauenarzt 60:656–660

Freis A, Freundl-Schütt T, Wallwiener LM, Baur S, Strowitzki T, Freundl G, Frank-Herrmann P (2018) Plausibility of menstrual cycle apps claiming to support conception. Front Public Health 3:98. https://doi.org/10.3389/fpubh.2018.00098 CrossRef

Freundl G (1991) Natürliche Familienplanung. Neue Technologien und Studien zur Methode. BMJFFG-Projekt, Düsseldorf, interner Abschlussbericht

Freundl G (1999) Welchen Wert haben pCO2-Messgeräte zur Empfängnisverhütung? Gynäkologische Praxis 23:202

Freundl G (2003) Natürliche Familienplanung und „nichthormonale Kontrazeption“. Gynäkologe 36:1099–1112 CrossRef

Freundl G, Baur S, Bremme M, Döring G, Frank-Herrmann P, Godehardt E et al (1992) Temperaturcomputer zur Bestimmung der fertilen Zeit im Zyklus der Frau: Babycomp, Bioself 110, Cyclotest D. Fertilität 8:66–76

Freundl G, Bremme M, Frank-Herrmann P, Baur S, Godehardt E, Sottong U (1996) The cue fertility monitor compared to ultrasound and LH peak measurements for fertile time ovulation detection. Adv Contracept 12:111–121 PubMedCrossRef

Freundl G, Bonnar J, Flynn AM, Frank-Herrmann P, Kirkman R, Snowden R (1998a) Effektivität eines neuen Verhütungscomputers „Persona“ Bericht über Testergebnisse in Deutschland. Fortschr Med 1:25–30

Freundl G, Frank-Herrmann P, Godehardt E, Klemm R, Bachhofer D (1998b) Retrospective clinical trial of contraceptive effectiveness of the electronic fertility indicator Ladycomp/Babycomp. Adv Contracept 14:97–108 PubMedCrossRef

Freundl G, Frank-Herrmann P, Godehardt E, Kern PA, Klose A, Koubenec HJ et al (2003a) Die Effektivität von Zyklusmonitoren zur Bestimmung des fertilen Fensters. Geburtshilfe Frauenheilkd 63:778–784 CrossRef

Freundl G, Godehardt E, Kern PA, Frank-Herrmann P, Koubenec HJ, Gnoth C (2003b) Estimated maximum failure rates of cycle monitors using daily conception probabilities in the menstrual cycle. Human Reproduction 18:2628–2633 PubMedCrossRef

Freundl G, Frank-Herrmann P, Godehardt E, Kern PA, Klose A, Koubenec HJ et al. (2003) Die Effektivität von Zyklusmonitoren zur Bestimmung des fertilen Fensters. Geburtshilfe Frauenheilkd 63:778–785

Freundl G, Frank-Herrmann P, Freundl-Schütt T, Görner K, Strowitzki T, Wallwiener LM, Gnoth C (2017) Fertilitäts- und Zyklus-Apps im Netz. Frauenarzt 58:378–381

Freundl G, Fehring RJ, Frank-Herrmann P, Gnoth C (2019) Study of contraceptive mobile app fails to provide convincing findings. Contraception. https://doi.org/10.1016/j.contraception.2018.07.141 CrossRefPubMed

Freundl-Schütt T, Wallwiener LM, Freundl G, Frank-Herrmann P (2019) Zyklus-Apps: Familienplanung der Zukunft? Geburtshilfe Frauenheilkd 79:676–678 https://doi.org/10.1055/a-0870-1751

Godbert S, Miro F, Shreeves C, Gnoth C, Johnson S (2015) Comparison between the different methods developed for determining the onset of the LH surge in urine during the human menstrual cycle. Arch Gynecol Obstet 292:1153–1161 PubMedCrossRef

Günther V, Bauer I, Hedderich J, Mettler L, Schubert M, Mackelenbergh MT, Maass N, Alkatout I (2015) Changes of salivary estrogen levels for detecting the fertile period. Europ J Obst Gynecol and Reprod Biol 194:38–42. https://doi.org/10.1016/j.ejogrb.2015.08.007 CrossRef

Guida M, Barbato M, Bruno P, Lauro G, Lampariello C (1993) Salivary ferning and the menstrual cycle in women. Clin Exp Obstet Gynecol 20:48–54 PubMed

Guida M, Tommaselli GA, Palomba S, Pellicano M, Moccia G, Di Carlo C et al (1999) Efficacy of methods for determining ovulation in a natural family planning program. Fertil Steril 72:900–904 PubMedCrossRef

Guida M, Bramante S, Acunzo G (2003) Diagnosis of fertility with a personal hormonal evaluation test. Minerva Ginecol 55:167–173 PubMed

Hadziomerovic D, Moeller K-T, Licht P, Hein A, Veitenhansel S, Kusmitsch M, Wildt L (2008) The biphasic pattern of end-expiratory carbon dioxide pressure: a method for identification of the fertile phase of the menstrual cycle. Fertil Steril 90:731–736 PubMedCrossRef

Hall N, White C, O’Sullivan AJ (2009) The relationship between adiponectin, progesterone, and temperature across the menstrual cycle. J Endocrinol Invest 32:279–283 PubMedCrossRef

Hartmann C (1965) An easily detected sign of impending or just completed ovulation. In: Keffer S (Hrsg) Human ovulation. Churchill, London

Jakob U, Britting R, Hetz W, Wildt L (1997) Die Messung des endexspiratorischen pCO2 zur Bestimmung des Ovulationszeitpunktes. Geburtshilfe Frauenheilkd 57:549–554 CrossRef

Johnson S, Marriott L, Zinaman M (2018) Can apps and calendar methods predict ovulation with accuracy? Curr Med Res Opin 34:1587–1594. https://doi.org/10.1080/03007995.2018.1475348 CrossRefPubMed

Johnson S, Weddell S, Godbert S, Freundl G, Roos J, Gnoth C (2015) Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day. Clin Chem Lab Med 53:1099–1108 PubMed

Keith M (1991) Home test to monitor fertility. Am J Obst Gynecol 165:2000–2003 CrossRef

Koch MC, Lermann J, van de Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, Kehl S, Oppelt PG, Hildebrandt T, Hack CC, Pöhls UG, Renner SP, Thiel FC (2018) Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app. Reprod Health 2:37. https://doi.org/10.1186/s12978-018-0479-6 CrossRef

Krotz S, McKenzie LJ, Cisneros P, Buster J, Amato P, Carson S (2005) Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos. Fertil Steril 83:1742–1744 PubMedCrossRef

Leiva R, Burhan U, Kyrillos E, Fehring R, McLaren R, Dalzell C, Tanguay E (2014) Use of ovulation predictor kits as adjuncts when using fertility awareness methods (FAMs): A pilot study. J Am Board Fam Med 27:427–429

Loewit K, Hoppichler F, Ledermuller G, Widhalm G (1990) Ovulation prediction from cyclic changes in salivary electrical conductivity [letter]. Am J Obstet Gynecol 163:708–710 PubMedCrossRef

Mancuso S, Bellante F, Marana R, Angelini A (1978) Chemical changes in saliva during the menstrual cycle. Acta Med Rom 16:387–403

McCarthy JJ, Rockette HE (1983) A comparison of methods to interpret the basal body temperature graph. Fertil Steril 39:640–646

McConnell HJ, O’Connor KA, Brindle E, Williams NI (2002) Validity of methods for analyzing urinary steroid data to detect ovulation in athletes. Med Sci Sports Exerc 34:1836–1844 PubMedCrossRef

Moeller K-T, Schmidt A, Licht P, Hein A, Veitenhansel S, Wildt L (2003) Expiratorische CO2-Messung in der Zyklusüberwachung – ein einfacher und zuverlässiger Marker zur Bestimmung der fertilen Tage. J Fertil Reprod 13:7–12

Moghissi KS (1973) Sperm migration through the human cervix. In: Elstein M (Hrsg) Cervical mucus and human reproduction. Scriptor, Copenhagen, S 128–152

Moghissi KS (1986) Cervical mucus changes and ovulation prediction and detection. J Reprod Med 31:748–753 PubMed

Moreno JE, Khan DF, Goldzieher JW (1997) Natural family planning: suitability of the CUE method for defining the time of ovulation. Contraception 55:233–237 PubMedCrossRef

Moreno JE, Weitzman GA, Doody MC, Gibbons WE, Besch P, Goldzieher JW (1988) Temporal relation of ovulation to salivary and vaginal electrical resistance patterns: implications for natural family planning. Contraception 38:407–418 PubMedCrossRef

Mu Q, Fehring RJ (2014) Efficacy of achieving pregnancy with fertility-focused intercourse. MCN Am J Matern Child Nurs. 39:35–40. https://doi.org/10.1097/nmc.0b013e3182a76b88 CrossRefPubMed

Niven DJ, Gaudet JE, Laupland KB, Mrklas KJ, Roberts DJ, Stelfox HAT (2015) Accuracy of peripheral thermometers for estimating temperature: a systematic review and meta-analysis. Ann Intern Med 163:768–777. https://doi.org/10.7326/m15-1150 CrossRefPubMed

Nulsen J et al (1987) Cervical mucus changes in relationship to urinary luteinizing hormone. Fertil Steril 48:783–786 PubMedCrossRef

O’Connor KA, Brindle E, Miller RC, Shofer JB, Ferrell RJ, Klein NA, Soules MR, Holman DJ, Mansfield PK, Wood JW (2006) Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierarchical method. Hum Reprod 21:1442–1452 PubMedCrossRef

Papaioannou S, Aslam M, Al Wattar BH, Milnes RC, Knowles TG (2012) Ovulation assessment by vaginal temperature analysis (the ovusense advanced fertility monitoring system) in comparison to oral temperature measurement. Fertil Steril 98:160–165. https://doi.org/10.1016/j.fertnstert.2012.07.590

Papaioannou S, Al Wattar BH, Milnes RC, Knowles TG (2013) Quality index assessment of vaginal temperature based fertility prediction and comparison with luteinising hormone testing, ultrasound folliculometry and other home cycle monitors. Fertil Steril 100(Suppl):326–327. https://doi.org/10.1016/j.fertnstert.2013.07.947 CrossRef

Papaioannou S, Delkos D, Pardey J (2014) Vaginal core body temperature assessment identifies pre-ovulatory body temperature rise and detects ovulation in advance of ultrasound folliculometry. European Society of Human Reproduction and Embryology 30th Annual Conference.

Park SJ, Goldsmith LT, Skurnick JH, Wojtczuk A, Weiss G (2007) Characteristics of the urinary luteinizing hormone surge in young ovulatory women. Fertil Steril 88:684–690 PubMedCrossRef

Polis CB (2018) Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed. Reprod Health 15:113. https://doi.org/10.1186/s12978-018-0560-1 CrossRefPubMedPubMedCentral

Prior JC, Vigna YM, Schulzer M, Hall JE, Bonen A (1990) Determination of luteal phase length by quantitative basal temperature methods: validation against the midcycle LH peak. Clin Invest Med 13:123–131 PubMed

Regidor PA, Kaczmarczyk M, Schiweck E, Goeckenjan-Festag M, Alexander H (2018) Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature. Gynecol Endocrinol 34:256–260. https://doi.org/10.1080/09513590.2017.1390737 CrossRefPubMed

Robinson JE, Wakelin M, Ellis JE (2007) Increased pregnancy rate with use of the clearblue easy fertility monitor. Fertil Steril 87:329–334 CrossRefPubMed

Rollason JC, Outtrim JG, Mathur RS (2014) A pilot study comparing the duofertility ^® monitor with ultrasound in infertile women. Int J Womens Health 16:657–662. https://doi.org/10.2147/ijwh.s59080.eCollection CrossRef

Roos J, Johnson S, Weddell S, Godehardt E, Schiffner J, Freundl G, Gnoth C (2015) Monitoring the menstrual cycle: comparison of urinary and serum reproductive hormones referenced to true ovulation. Eur J of Contracept Reprod Health Care 20:438–450 CrossRef

Rotta L, Matechova E, Cerny M, Pelak Z (1992) Determination of the fertile period during the menstrual cycle in women by monitoring changes in crystallization of saliva with the PC2000 IMPCON minimicroscope. Cesk Gynekol 57:340–352 PubMed

Roumen FJ, Dieben TO (1988) Ovulation prediction by monitoring salivary electrical resistance with the cue fertility monitor. Obstet Gynecol 71:49–52 PubMed

Schimmoeller N, Creinin MD (2018) More clarity needed for contraceptive mobile app Pearl Index calculations. Contraception 97:456 https://doi.org/10.1016/j.contraception.2018.01.005

Sektion Natürliche Fertilität (2012) Empfängnisverhütung bei der Frau: Natürliche Methoden. In: Rabe T (Hrsg) Seminar in Gynäkologischer Endokrinologie. Thomas Rabe, Heidelberg, ISBN 9783000390777

Severy L (2001) Acceptability of home monitoring as an aid to conception. J Int Med Res 29(Suppl 1):28A–34A PubMedCrossRef

Shilaih M, Clerck V, Falco L, Kübler F, Leeners B (2017a) Pulse rate measurement during sleep using wearable sensors, and its correlation with the menstrual cycle phases, a prospective observational study. Sci Rep. 7:1294. https://doi.org/10.1038/s41598-017-01433-9 CrossRefPubMedPubMedCentral

Shilaih M, Goodale BM, Falco L, Kübler F, De Clerck V, Leeners B (2017b) Modern fertility awareness methods: wrist wearables capture the changes of temperature associated with the menstrual cycle. Biosci Rep. pii: BSR20171279. https://doi.org/10.1042/bsr20171279

Simmons RG, Shattuck DC, Jennings VH (2017) Assessing the efficacy of an app-based method of family planning: the dot study protocol. JMIR Res Protocol 6:e5 CrossRef

Sohda S, Suzuki K, Igari I (2017) Relationship between the menstrual cycle and timing of ovulation revealed by new protocols: analysis of data from a self-tracking. Health AppJ Med Internet Res 19:e391 http://www.jmir.org/2017/11/e391

Stein P, Falco L, Kuebler F, Annaheim S, Lemkaddem A, Delgado-Gonzalo R, Verjus C, Leeners B (2016) Digital womens health based on wearables and big data. Fertil Steril 106:113 CrossRef

Tanabe K, Susumu N, Hand K, Nishii K, Ishikawa I, Nozawa S (2001) Prediction of the potentially fertile period by urinary hormone measurements using a new home-use monitor: comparison with laboratory hormone analyses. Hum Reprod 16:1619–1624 PubMedCrossRef

Thornton SJ, Pepperell RJ, Brown JB (1990) Home monitoring of gonadotropin ovulation induction using the ovarian monitor. Fertil Steril 54:1076–1082 PubMedCrossRef

Toncaboni RF (1991) Die Bestimmung der fruchtbaren Tage im Zyklus der Frau mittels Babycomp: eine Pilotstudie. Med Dissertation, Universität Düsseldorf

Trussell J (1999) Contraceptive efficacy of the personal hormone monitoring system Persona. Br J FamPlann 25:34–35

Trussell J (2001) Measuring the contraceptive efficacy of Persona. Contraception 63:77–79 PubMedCrossRef

TÜV Süd Persönliche Mitteilung, E-Mail vom 23.02.2017

Usala SJ, Schumacher GF (1983) Volumetric self-sampling of cervicovaginal fluid: a new approach to ovulation timing. Fertil Steril 39:304–309 PubMedCrossRef

Wang J, Usala SJ, O’Brien-Usala F, Biggs WC, Vaughn MW, McKenna GB (2009) The fertile and infertile phases of the menstrual cycle are signaled by cervical-vaginal fluid die swell functions. The Endocrinologist 19:291–297 CrossRef

Titel: Zyklus-Apps und Mess-Systeme
verfasst von: Elisabeth Raith-Paula
Petra Frank-Herrmann
Verlag: Springer Berlin Heidelberg
Buch: Natürliche Familienplanung heute
Print ISBN: 978-3-662-59310-3

Electronic ISBN: 978-3-662-59311-0

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/978-3-662-59311-0_14

Neu im Fachgebiet Gynäkologie und Geburtshilfe

24.03.2023 | FOKO 2023 | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

14. Zyklus-Apps und Mess-Systeme

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Onkologische Nachsorge in Zeiten neuer Therapiemöglichkeiten

Mamma-Ca. in der Schwangerschaft: so nah wie möglich an der Standardtherapie

Schwangerschaft Ü40: Mutter und Kind durch individuelle Risikostratifizierung schützen

Dysmenorrhö und Endometrioseschmerz: Chronifizierung vermeiden

Update Gynäkologie

Update Gynäkologie

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Onkologische Nachsorge in Zeiten neuer Therapiemöglichkeiten

Mamma-Ca. in der Schwangerschaft: so nah wie möglich an der Standardtherapie

Schwangerschaft Ü40: Mutter und Kind durch individuelle Risikostratifizierung schützen

Dysmenorrhö und Endometrioseschmerz: Chronifizierung vermeiden

Update Gynäkologie

Update Gynäkologie